Exports In 2020, China exported $3.21B in Blood, antisera, vaccines, toxins and cultures, making it the 12th largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 155th most exported product in China. The main destination of Blood, antisera, vaccines, toxins and cultures exports from China are: United States ($420M), Germany ($391M), United Kingdom ($379M), Brazil ($301M), and Russia ($151M).
The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of China between 2019 and 2020 were United Kingdom ($356M), Germany ($341M), and United States ($279M).
Imports In 2020, China imported $9.26B in Blood, antisera, vaccines, toxins and cultures, becoming the 6th largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 28th most imported product in China. China imports Blood, antisera, vaccines, toxins and cultures primarily from: Switzerland ($3.08B), United States ($1.93B), Germany ($1.36B), Belgium ($793M), and Ireland ($567M).
The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for China between 2019 and 2020 were Switzerland ($1.01B), Belgium ($668M), and Ireland ($128M).
Tariffs In 2018, the average tariff for China in Blood, antisera, vaccines, toxins and cultures was 2.34%. The countries with the highest import tariffs for Blood, antisera, vaccines, toxins and cultures were Burkina Faso (Most Favoured Nation duty rate treatement, 3%), Botswana (Most Favoured Nation duty rate treatement, 3%), Cote d'Ivoire (Most Favoured Nation duty rate treatement, 3%), Cameroon (Most Favoured Nation duty rate treatement, 3%), and Democratic Republic of the Congo (Most Favoured Nation duty rate treatement, 3%).